Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Clin Cancer Res. 2021 Jan 27;27(7):2111–2118. doi: 10.1158/1078-0432.CCR-20-2245

Table 1.

Sequencing, demographic and clinical profile of the 9.11 WTC cohort.

Sample WTC exposure Age at Diagnosis Year of diagnosis Stage Sex Isotype IGH translocation Coverage Purity Ploidy
IID_H196059 First responder 67 2019 MGUS M IgG kappa/ lambda% HRD* 49.19 0.35 2.45
IID_H135336 First responder 50 2014 SMM M IgG lambda HRD 76.54 0.40 2.18
IID_H196060 First responder 48 2017 PCL M IgG lambda t(14;16) 48.76 0.96 1.9
IID_H130588 First responder 57 2018 MM M IgG kappa HRD 50.39 0.86 2.29
IID_H196061 First responder 52 2019 MGUS M IgA kappa t(11;14) 51.73 0.45 2.48
IID_H196062 First responder 58 2019 SMM M IgG lambda t(6;14) 47.57 0.31 1.99
IID_H196063 First responder 61 2019 MGUS M IgG lambda HRD 47.85 0.5 2.81
IID_H196064 First responder 65 2019 MGUS M IgG lambda - 51.46 0.86 1.9
IID_H135225 Rescue worker 47 2015 MM M IgG kappa t(2;16)(IGL-MAF) 76.22 0.98 1.89
*

HRD: hyperdiploid

%

biclonal